Korkes Fernando, Rodrigues Antônio Flávio Silva, Baccaglini Willy, Cunha Frederico Timóteo Silva, Slongo Júlio, Spiess Philippe, Glina Sidney
Faculdade de Medicina do ABC, Santo André, SP, Brazil.
University of South Florida, Tampa, United States.
Einstein (Sao Paulo). 2020 Nov 6;18:eAO5577. doi: 10.31744/einstein_journal/2020AO5577. eCollection 2020.
To gather information on penile cancer epidemiologic trends and its economic impact on the Brazilian Public Health System across the last 25 years.
The Brazilian Public Health System database was used as the primary source of data from January 1992 to December 2017. Mortality and incidence data from the Instituto Nacional de Câncer José Alencar Gomes da Silva was collected using the International Classification of Diseases ICD10 C60. Demographic data from the Brazilian population was obtained from the last census by the Brazilian Institute of Geography and Statistics, performed in 2010 and its 2017 review.
There were 9,743 hospital admissions related to penile cancer from 1992 to 2017. There was a reduction (36%) in the absolute number of admissions per year related to penile cancer in 2017, as compared to 1992 (2.7versus 1.7 per 100,000; p<0.001). The expenses with admissions related to this condition in this period were US$ 3,002,705.73 (US$ 115,488.68/year). Approximately 38% of the total amount was spent in Northeast Region. In 1992, penile cancer costed US$ 193,502.05 to the public health system, while in 2017, it reduced to US$ 47,078.66 (p<0.02). Penile cancer incidence in 2017 was 0.43/100,000 male Brazilian, with the highest incidence rate found in the Northeast Region. From 1992 to 2017, the mortality rates of penile cancer in Brazil were 0.38/100,000 man, and 0.50/100,000 man in the North Region.
Despite the decrease in admissions, penile cancer still imposes a significant economic and social burden to the Brazilian population and the Public Health System.
收集过去25年巴西阴茎癌的流行病学趋势及其对巴西公共卫生系统的经济影响的信息。
1992年1月至2017年12月期间，巴西公共卫生系统数据库被用作主要数据来源。使用国际疾病分类ICD10 C60收集了若泽·阿伦卡尔·戈麦斯·达席尔瓦国家癌症研究所的死亡率和发病率数据。巴西人口的人口统计数据来自巴西地理与统计研究所2010年进行的上一次人口普查及其2017年的复查。
1992年至2017年，共有9743例与阴茎癌相关的住院病例。与1992年相比，2017年每年与阴茎癌相关的住院绝对病例数减少了36%（每10万人中分别为2.7例和1.7例；p<0.001）。在此期间，与该疾病相关的住院费用为3002705.73美元（每年115488.68美元）。总费用的约38%花在了东北地区。1992年，阴茎癌给公共卫生系统造成的费用为193502.05美元，而在2017年，降至47078.66美元（p<0.02）。2017年巴西男性阴茎癌发病率为0.43/10万，东北地区发病率最高。1992年至2017年，巴西阴茎癌死亡率为0.38/10万男性，北部地区为0.50/10万男性。
尽管住院病例数有所下降，但阴茎癌仍然给巴西人口和公共卫生系统带来了巨大的经济和社会负担。
